Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 5.

Britton, David James, Hutcheson, Iain Robert, Knowlden, Janice Mary, Barrow, Denise, Giles, Martin Gwyn, McClelland, Richard Andrew, Gee, Julia Margaret Wendy and Nicholson, Robert Ian 2006. Bidirectional cross talk between ER alpha and EGFR signalling pathways regulates tamoxifen-resistant growth. Breast Cancer Research and Treatment 96 (2) , pp. 131-146. 10.1007/s10549-005-9070-2

Nicholson, Robert Ian, Hutcheson, Iain Robert, Hiscox, Stephen Edward, Knowlden, Janice Mary, Giles, Martin Gwyn, Barrow, Denise and Gee, Julia Margaret Wendy 2005. Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer. Endocrine-Related Cancer 12 (S1) , S29-S36. 10.1677/erc.1.00991

Giles, Martin Gwyn, Fiegl, H., Widschwendter, M., Gee, Julia Margaret Wendy, Wakeling, A. E. and Nicholson, Robert Ian 2005. Loss of estrogen receptor (ER) expression in MCF-7 cells following long-term exposure to fulvestrant [Abstract]. Breast Cancer Research and Treatment 94 (S1) , S243. 10.1007/s10549-005-1234-6

Gee, Julia Margaret Wendy, Giles, Martin Gwyn and Nicholson, Robert Ian 2004. Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer. Breast Cancer Research 6 (4) , pp. 162-163. 10.1186/bcr904
file

Giles, Martin Gwyn, Gee, Julia Margaret Wendy, Wakeling, A. E. and Nicholson, Robert Ian 2004. Characterization of ER alpha and cofactor recruitment during fulvestrant treatment and resistance in breast cancer using chromatin immunoprecipitation [Abstract]. Breast Cancer Research and Treatment 88 (S1) , S216-S217. 10.1007/s10549-004-3602-z

This list was generated on Sun Oct 13 09:08:24 2019 BST.